Stoke Therapeutics(STOK) - 2020 Q2 - Quarterly Report

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR Commission File Number: 001-38938 Stoke Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 47-1144582 (State or other jurisdiction of incorporation or organization) 45 Wiggins Ave Bedford, Massachusetts 01730 (Address of principal executive offices) (Zip Code) (I.R ...